Sebastian Attig

6.2k total citations
22 papers, 781 citations indexed

About

Sebastian Attig is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Sebastian Attig has authored 22 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 13 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Sebastian Attig's work include Immunotherapy and Immune Responses (12 papers), CAR-T cell therapy research (8 papers) and Immune Cell Function and Interaction (7 papers). Sebastian Attig is often cited by papers focused on Immunotherapy and Immune Responses (12 papers), CAR-T cell therapy research (8 papers) and Immune Cell Function and Interaction (7 papers). Sebastian Attig collaborates with scholars based in Germany, United States and Netherlands. Sebastian Attig's co-authors include Cécile Gouttefangeas, Sven D. Koch, Graham Pawelec, Uğur Şahin, Dennis Özcelik, Anders Wikby, Anis Larbi, Jan Strindhall, Claudio Franceschi and Rafael Solana and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer Research.

In The Last Decade

Sebastian Attig

22 papers receiving 765 citations

Peers

Countries citing papers authored by Sebastian Attig

Since Specialization

Citations

This map shows the geographic impact of Sebastian Attig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sebastian Attig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sebastian Attig more than expected).

Fields of papers citing papers by Sebastian Attig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sebastian Attig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sebastian Attig. The network helps show where Sebastian Attig may publish in the future.

Co-authorship network of co-authors of Sebastian Attig

This figure shows the co-authorship network connecting the top 25 collaborators of Sebastian Attig. A scholar is included among the top collaborators of Sebastian Attig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sebastian Attig. Sebastian Attig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Analysis of RBP expression and binding sites identifies PTBP1 as a regulator of CD19 expression in B-ALL 2023 ·OncoImmunology ·(unknown), Mariela Cortés-López, Francesca Alt, (unknown), (unknown), Nadine Lehmann, Khalifa El Malki, Arthur Wingerter, Alexandra Russo, Olaf Beck, Sebastian Attig, Lea Roth, Julian König, Claudia Paret, Jörg Faber	3
2	The gut microbiota instructs the hepatic endothelial cell transcriptome 2021 ·iScience ·(unknown), Joana P. Bernardes, Amrit Mann, Franziska Bayer, Giulia Pontarollo, Klytaimnistra Kiouptsi, Katrin Schäfer, Sebastian Attig, Teodora Nikolova, Thomas G. Hofmann, Jörn M. Schattenberg, Hristo Todorov, Susanne Gerber, Philip Rosenstiel, Tobias Bopp, Felix Sommer, Christoph Reinhardt	17
3	88MO T-cell responses induced by an individualized neoantigen specific immune therapy in post (neo)adjuvant patients with triple negative breast cancer 2020 ·Annals of Oncology ·Marcus Schmidt, Isabel Vogler, Evelyna Derhovanessian, Tana Omokoko, (unknown), Sebastian Attig, Andrea Cortini, Sebastian Newrzela, (unknown), Stefanie Bolte, Daniël Langer, Michael Eichbaum, Henrik Lindman, Steve Pascolo, Andreas Schneeweiß, Tobias Sjöblom, Özlem Türeci, Uğur Şahin	23
4	A shared tumor-antigen RNA-lipoplex vaccine with/without anti-PD1 in patients with checkpoint-inhibition experienced melanoma. 2020 ·Journal of Clinical Oncology ·Carmen Loquai, Jessica C. Hassel, Petra Oehm, Evelyna Derhovanessian, Robert A. Jabulowsky, Maike Gold, Doreen Schwarck-Kokarakis, Sebastian Attig, Katarina Ćuk, Isabel Vogler, Julian Sikorski, (unknown), Heidrun Mitzel-Rink, Matthias Miederer, Stephan Grabbe, Jochen Utikal, Andreas Pinter, Roland Kaufmann, Uğur Şahin, (unknown)	17
5	IVAC MUTANOME: A first-in-human phase I clinical trial targeting individual mutant neoantigens for the treatment of melanoma 2017 ·Annals of Oncology ·Matthias Miller, Uğur Şahin, Evelyna Derhovanessian, (unknown), Petra Simon, Valesca Bukur, (unknown), Anna Paruzynski, Martin Löwer, Andreas N. Kuhn, Katharina Schreeb, Sebastian Attig, (unknown), Stefanie Bolte, Stephan Grabbe, Christoph Höller, Jochen Utikal, Christian G. Huber, Carmen Loquai, Özlem Türeci	13
6	A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for potent melanoma immunotherapy 2017 ·Annals of Oncology ·Ludwig Heesen, Robert A. Jabulowsky, Carmen Loquai, Jochen Utikal, Christoffer Gebhardt, Jessica C. Hassel, Roland Kaufmann, Andreas Pinter, Evelyna Derhovanessian, Mustafa Diken, Lena M. Kranz, Heinrich Haas, Sebastian Attig, Andreas N. Kuhn, Peter Langguth, Doreen Schwarck-Kokarakis, Dirk Jäger, Stephan Grabbe, Özlem Türeci, Uğur Şahin	9
7	CD19 Isoforms Enabling Resistance to CART-19 Immunotherapy Are Expressed in B-ALL Patients at Initial Diagnosis 2017 ·Journal of Immunotherapy ·(unknown), Claudia Paret, Khalifa El Malki, Francesca Alt, Arthur Wingerter, Marie A. Neu, (unknown), Alexandra Russo, Nadine Lehmann, Lea Roth, (unknown), Sebastian Attig, (unknown), Thomas Kindler, Jörg Faber	168
8	Data analysis as a source of variability of the HLA-peptide multimer assay: from manual gating to automated recognition of cell clusters 2015 ·Cancer Immunology Immunotherapy ·Cécile Gouttefangeas, Cliburn Chan, Sebastian Attig, Tania Køllgaard, Hans‐Georg Rammensee, Stefan Stevanović, Dorothee Wernet, Per thor Straten, Marij J.P. Welters, Christian H. Ottensmeier, Sjoerd H. van der Burg, Cedrik M. Britten	14
9	Functional TCR Retrieval from Single Antigen-Specific Human T Cells Reveals Multiple Novel Epitopes 2014 ·Cancer Immunology Research ·Petra Simon, Tana Omokoko, Andrea Breitkreuz, (unknown), Sebastian Kreiter, Sebastian Attig, Abdo Konur, Cedrik M. Britten, Claudia Paret, Karl Dhaene, Özlem Türeci, Uğur Şahin	32
10	Phenotyping of peripheral blood mononuclear cells of patients with advanced heavily pre-treated adenocarcinoma of the stomach and gastro-esophageal junction 2014 ·Cancer Immunology Immunotherapy ·(unknown), Sebastian Attig, Cedrik M. Britten, Henning Schulze‐Bergkamen, Florian Lordick, Goetz von Wichert, Peter Thuss‐Patience, Alexander Stein, Martin Schüler, Florian Bassermann, Uğur Şahin, Özlem Türeci	1
11	Improved method to retain cytosolic reporter protein fluorescence while staining for nuclear proteins 2014 ·Cytometry Part A ·André P. Heinen, Florian Wanke, Sonja Moos, Sebastian Attig, Hervé Luche, Prajna Paramita Pal, Nediljko Budiša, Hans Jörg Fehling, Ari Waisman, Florian C. Kurschus	25
12	mTOR Inhibition Improves Antitumor Effects of Vaccination with Antigen-Encoding RNA 2013 ·Cancer Immunology Research ·Mustafa Diken, Sebastian Kreiter, Fulvia Vascotto, Abderraouf Selmi, Sebastian Attig, Jan Diekmann, Christoph Huber, Özlem Türeci, Uğur Şahin	39
13	CIMT 2013 2013 ·Human Vaccines & Immunotherapeutics ·Mustafa Diken, Sebastian Attig, Christian Grunwitz, Lena M. Kranz, Petra Simon, Niels van de Roemer, Fulvia Vascotto, Sebastian Kreiter	1
14	Serum-free freezing media support high cell quality and excellent ELISPOT assay performance across a wide variety of different assay protocols 2012 ·Cancer Immunology Immunotherapy ·(unknown), Sebastian Attig, Nicole Bidmon, Bernhard Y. Renard, Sylvia Janetzki, Uğur Şahin, Marij J.P. Welters, Christian H. Ottensmeier, Sjoerd H. van der Burg, Cécile Gouttefangeas, Cedrik M. Britten	20
15	FLT3 Ligand Enhances the Cancer Therapeutic Potency of Naked RNA Vaccines 2011 ·Cancer Research ·Sebastian Kreiter, Mustafa Diken, Abderraouf Selmi, Jan Diekmann, Sebastian Attig, Yves Hüsemann, Michael Koslowski, Christoph Huber, Özlem Türeci, Uğur Şahin	62
16	Promiscuous survivin peptide induces robust CD4⁺ T‐cell responses in the majority of vaccinated cancer patients 2011 ·International Journal of Cancer ·(unknown), (unknown), Stefan Stevanović, Susan Feyerabend, Reinhild Klein, Sebastian Attig, Jörg Hennenlotter, Dorothee Wernet, Dmitry V. Kuprash, (unknown), Steve Pascolo, Arnulf Stenzl, Cécile Gouttefangeas, Hans‐Georg Rammensee	51
17	A critical assessment for the value of markers to gate-out undesired events in HLA-peptide multimer staining protocols 2011 ·Journal of Translational Medicine ·Sebastian Attig, Leah Price, Sylvia Janetzki, Michael Kalos, Michael W. Pride, Lisa K. McNeil, (unknown), Jianda Yuan, Kunle Odunsi, Axel Hoos, Pedro Romero, Cedrik M. Britten, (unknown)	17
18	Simultaneous Infiltration of Polyfunctional Effector and Suppressor T Cells into Renal Cell Carcinomas 2009 ·Cancer Research ·Sebastian Attig, Jörg Hennenlotter, Graham Pawelec, Gerd Klein, Sven D. Koch, Hanspeter Pircher, Susan Feyerabend, Dorothee Wernet, Arnulf Stenzl, Hans‐Georg Rammensee, Cécile Gouttefangeas	76
19	Cytomegalovirus Infection 2007 ·Annals of the New York Academy of Sciences ·Sven D. Koch, Anis Larbi, Dennis Özcelik, Rafael Solana, Cécile Gouttefangeas, Sebastian Attig, Anders Wikby, Jan Strindhall, Claudio Franceschi, Graham Pawelec	180
20	Studies of S-adenosylhomocysteine-hydrolase polymorphism in a Croatian population 2005 ·Journal of Human Genetics ·Doris Kloor, Ksenija Fumić, Sebastian Attig, (unknown), Hartmut Oßwald, Ivo Barić, Jürgen Tomiuk, J. Kömpf	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact